Cite
HARVARD Citation
Höchsmann, B. et al. (2022). Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real‐world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry. European journal of haematology. pp. 197-204. [Online].